Olema Pharmaceuticals Inc
Research Olema Pharmaceuticals Inc (OLMA) on Bullrun: market cap USD 643.65M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerOLMA
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 643.65M
- Financial periodQ2 2026
- RevenueUSD 0
- Net income-USD 63.20M
- Free cash flow-USD 46.12M
Valuation Snapshot
latest market cap is USD 643.65M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 162.45M | -USD 146.72M | n/a | -1.87 | USD 48.30M | USD 4.19M | USD 478.56M |
| FY2024 | USD 0 | -USD 129.47M | -USD 104.51M | n/a | -2.2 | USD 139.48M | USD 1.43M | USD 408.96M |
| FY2023 | USD 0 | -USD 96.66M | -USD 83.73M | n/a | -2.14 | USD 68.54M | USD 2.42M | USD 253.90M |
| FY2022 | USD 0 | -USD 104.79M | -USD 82.43M | n/a | -2.62 | USD 23.70M | USD 2.57M | USD 197.55M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 643.65M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 2.03B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 433.24M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 768.42M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 99.12M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 372.50M | n/a | n/a | n/a |
About Olema Pharmaceuticals Inc
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. The company's lead product candidate is palazestrant, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 3 clinical trial for the treatment of recurrent, locally advanced, or metastatic ER-positive, human epidermal growth factor receptor 2-negative breast cancer;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Olema Pharmaceuticals Inc's market cap?
Olema Pharmaceuticals Inc's market capitalization is USD 643.65M.
What does Olema Pharmaceuticals Inc do?
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers.